French UFC flyweight fighter Manon Fiorot received a three-month suspension for breaching the promotion’s anti-doping policy after testing positive for a prohibited substance during screening.
The UFC announced on Thursday that the 36-year-old agreed to serve the suspension after low levels of Ostarine were detected in her sample.
Fiorot, ranked fourth in the UFC women’s flyweight rankings, tested positive on September 12, the very same day she was defeated by Alexa Grasso in a title eliminator bout.
According to a statement issued by Combat Sports Anti-Doping (CSAD), Fiorot noted that her nutritionist had supplied multiple dietary supplements unfamiliar to her regimen during the fight week.
Analyses performed on the supplements allegedly detected minute quantities of Ostarine, a substance banned by the UFC’s anti-doping policy.
Another specimen gathered on October 16, prior to Fiorot being informed about the violation, produced negative results.
Ostarine is a selective androgen receptor modulator (SARM) initially developed for medical uses, including aiding patients with muscle-wasting diseases to regain muscle.
The substance is forbidden at all times under the UFC’s anti-doping programme.
Fiorot was initially facing a potential six-month ban, though the UFC said her cooperation with the investigation helped reduce the overall penalty.
Her three-month suspension is set to conclude on January 19, 2027.
The UFC’s anti-doping program is overseen by CSAD, whereas Drug Free Sport carries out all sample collection.


